Judith Wagner – författare
Visar alla böcker från författaren Judith Wagner. Handla med fri frakt och snabb leverans.
5 produkter
5 produkter
E-bok
PDF, Engelska, 2005811 kr
Läs direkt efter köp
The National Cancer Policy Board and the Board on Science, Engineering, and Economic Policy convened a workshop in January 2004 on "Economic Models of Colorectal Cancer (CRC) Screening in Average-Risk Adults". The purpose of the workshop was to explore the reasons for differences among leading cost-effectiveness analysis (CEA) models of CRC screening, which public health policy makers increasingly rely on to help them sift through the many choices confronting them. Participants discussed the results of a collaborative pre-workshop exercise undertaken by five research teams that have developed and maintained comprehensive models of CRC screening in average-risk adults, to gain insight into each model''s structure and assumptions and possible explanations for differences in their published analyses. Workshop participants also examined the current state of knowledge on key inputs to the models with a view toward identifying areas where further research may be warranted. This document summarized the presentations and discussion at the workshop.
Del 65 - Orbis Phaenomenologicus Studien
Schmerz und seine Grenzen
Häftad, Tyska, 2025
423 kr
Skickas inom 3-6 vardagar
Häftad, Engelska, 2011
556 kr
Skickas inom 10-15 vardagar
This book discusses the various methods to reprogram cells, the control and determination of cell identity, the epigenetic models that have emerged and the application of iPS cell therapy for brain diseases, in particular Parkinson’s disease and Vanishing White Matter (VWM).?
E-bok
PDF, Engelska, 2011708 kr
Läs direkt efter köp
Brain diseases can have a large impact on patients and society, and treatment is often not available. A new approach in which somatic cells are reprogrammed into induced pluripotent cells (iPS cells) is a significant breakthrough for regenerative medicine. This promises patient-specific tissue for replacement therapies, as well as disease-specific cells for developmental modeling and drug treatment screening. However, this method faces issues of low reprogramming efficiency, and poorly defined criteria for determining the conversion of one cell type to another. Cells contain epigenetic “memories” of what they were that can affect reprogramming. This book discusses the various methods to reprogram cells, the control and determination of cell identity, the epigenetic models that have emerged and the application of iPS cell therapy for brain diseases, in particular Parkinson’s disease and Vanishing White Matter (VWM).
Häftad, Engelska, 2005
904 kr
Tillfälligt slut
The National Cancer Policy Board and the Board on Science, Engineering, and Economic Policy convened a workshop in January 2004 on a /Economic Models of Colorectal Cancer (CRC) Screening in Average-Risk Adultsa . The purpose of the workshop was to explore the reasons for differences among leading cost-effectiveness analysis (CEA) models of CRC screening, which public health policy makers increasingly rely on to help them sift through the many choices confronting them. Participants discussed the results of a collaborative pre-workshop exercise undertaken by five research teams that have developed and maintained comprehensive models of CRC screening in average-risk adults, to gain insight into each modela (TM)s structure and assumptions and possible explanations for differences in their published analyses. Workshop participants also examined the current state of knowledge on key inputs to the models with a view toward identifying areas where further research may be warranted. This document summarized the presentations and discussion at the workshop.